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ABSTRACT
Given their obligate intracellular lifestyle, Chlamydia trachomatis
ensure that they have access to multiple host sources of essential
lipids by interfering with vesicular transport. These bacteria hijack
Rab6-, Rab11- and Rab14-controlled trafficking pathways to acquire
sphingomyelin from the Golgi complex. Another important source of
sphingolipids, phospholipids and cholesterol are multivesicular
bodies (MVBs). Despite their participation in chlamydial inclusion
development and bacterial replication, the molecular mechanisms
mediating the interaction between MVBs and chlamydial inclusions
remain unknown. In the present study, we demonstrate that Rab39a
labels a subset of late endocytic vesicles – mainly MVBs – that move
along microtubules. Moreover, Rab39a is actively recruited to
chlamydial inclusions throughout the pathogen life cycle by a
bacterial-driven process that depends on the Rab39a GTP- or
GDP-binding state. Interestingly, Rab39a participates in the delivery
of MVBs and host sphingolipids to maturing chlamydial inclusions,
thereby promoting inclusion growth and bacterial development.
Taken together, our findings indicate that Rab39a favours
chlamydial replication and infectivity. This is the first report showing
that a late endocytic Rab GTPase is involved in chlamydial infection
development.
KEY WORDS: Chlamydia trachomatis, Rab, Rab39a, Multivesicular
bodies, Pathogen–host-cell interaction, Lipid transport
INTRODUCTION
Infections caused by Chlamydia trachomatis have a substantial
impact on public health. Recurring chlamydial infections can lead to
permanent sequelae such as blinding trachoma and female
infertility. This widely spread human pathogen is an obligate
intracellular Gram-negative bacterium, which undergoes its entire
life cycle inside a vacuole called an inclusion. The infectious cycle
starts with the attachment of the elementary body – the infectious
bacterial form – to the host epithelial cell. This is followed by
the triggering of a signalling cascade that culminates with the
internalization of the bacterium. Once inside the host cell, the
elementary body rapidly differentiates into the metabolically active,
but non-infectious, bacterial form known as the reticulate body.
Inclusion growth and bacterial replication depends on the
acquisition of nutrients and biosynthetic constituents from the
host. Following multiple rounds of replication, reticulate bodies re-
differentiate back into elementary bodies and leave infected cells by
lysis or extrusion, after which bacteria disseminate and invade
neighbouring cells (Bastidas et al., 2013; Damiani et al., 2014).
The success of this pathogen resides in the relationship with the
infected cell. To date, the molecular players mediating this
pathogen–host interaction remain largely unknown. It is thought
that chlamydial effectors exposed at the inclusion membrane,
named Inc proteins, participate in the interplay between the bacteria
and the host cell (Betts et al., 2009; Dehoux et al., 2011; Valdivia,
2008). However, it is unclear how these bacterial molecules infringe
on host cell functioning. Furthermore, very little is known about
how C. trachomatis co-opts the host cell protein machinery to
ensure its survival and replication.
C. trachomatis growth and replication rely heavily upon the
acquisition of certain lipids, mainly sphingolipids and cholesterol,
from eukaryotic host cells (Saka and Valdivia, 2010). Interestingly,
C. trachomatis acquire lipids through non-vesicular and vesicular
mechanisms: (1) by recruiting transporters and synthases from host
cytosolic sphingolipid factories at the boundaries of inclusions
(Derré et al., 2011; Elwell et al., 2011) and (2) from Golgi-derived
exocytic vesicles and multivesicular bodies (MVBs) (Beatty, 2006;
Cocchiaro et al., 2008; Hackstadt et al., 1996; Moore et al., 2008).
MVBs are organelles that are strategically located at the
intersection of endocytic and exocytic pathways. In addition to
their pivotal role in exogenous material sorting, MVBs are potential
intermediates in the transport of Golgi-derived vesicles (Denzer
et al., 2000; Huotari and Helenius, 2011; Piper and Katzmann,
2007; Stoorvogel et al., 2002; Woodman and Futter, 2008).
Particularly abundant in sphingolipids, lysobisphosphatidic acid
(LBPA) and cholesterol, MVBs are a main source of host lipids
hijacked by bacteria (Beatty, 2006, 2008; Robertson et al., 2009).
Despite the importance of these late endocytic organelles for
chlamydial development, the host protein machinery exploited by
these bacteria to promote MVB–inclusion interaction is currently
unknown.
Rab proteins (hereafter referred to as ‘Rabs’) are the largest
family in the Ras-like small GTPase super family and tightly control
vesicular trafficking. There are more than 60 distinct Rabs in
mammalian cells and each one regulates a particular transport event.
Rabs regulate sorting and budding from donor compartments,
vesicular movement on cytoskeleton trails, proper targeting of
vesicles, and docking and fusion with acceptor partners. These
GTPases act as molecular switches, cycling between an inactive
GDP-bound state and an active GTP-bound form, that latter of
which is engaged with its specific target membrane (Ali and Seabra,
2005; Stenmark, 2009; Zerial and McBride, 2001). A few reports
have investigated the localization of Rabs on MVBs, primarily
identifying Rab7 and Rab11 (Fukuda et al., 2008; Savina et al.,
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C. trachomatis interfere with the host Rab-dependent vesicular
trafficking pathways in order to generate hospitable intracellular
conditions for bacterial survival and multiplication (Rzomp et al.,
2003). By avoiding the interaction with Rab5 and Rab7,
C. trachomatis escape from degradation in the phagocytic
pathway (Fields and Hackstadt, 2002). In contrast, recruitment of
Rab6 (Rejman Lipinski et al., 2009), Rab11 (Leiva et al., 2013;
Rejman Lipinski et al., 2009) and Rab14 (Capmany and Damiani,
2010; Capmany et al., 2011) to the inclusion membrane is
advantageous for bacterial nutrient acquisition from the host
intracellular compartments.
Rab39, a short variant of Rab34, has two isoforms, Rab39a and
Rab39b, with 78% identity at the amino acid level (Becker et al.,
2009; Chen et al., 2003). Rab39a and Rab39b display different
intracellular distribution. Rab39a is associated with late endosomes
and lysosomes, and regulates endocytosis, acidification of maturing
phagosomes, autophagosome formation and secretion of pro-
inflammatory compounds (Becker et al., 2009; Mori et al., 2013;
Seto et al., 2011, 2013). In contrast, Rab39b is mainly concentrated
at the Golgi complex, and regulates the trafficking to synaptic
terminals of glutamate receptors, synaptic transmission, and growth
and differentiation of neuronal cells (Giannandrea et al., 2010;
Mignogna et al., 2015).
Our work uncovers a new role for the previously
uncharacterized Rab39a as a MVB-associated Rab protein that
is involved in the targeting of MVBs to chlamydial inclusions.
Here, we show that endogenous Rab39a is recruited to chlamydial
inclusions. Interestingly, a subset of Rab39a-labelled vesicular
structures, likely exosomes delivered by fusion with MVBs, is
found within the inclusion lumen. Rab39a is associated with
inclusions in different cell types throughout the bacterial
developmental life cycle, and this association is mediated by a
bacteria-driven process. Rab39a redistribution to chlamydial
inclusion surroundings is highly dynamic and depends on its
GTP- or GDP-binding state. Nocodazole treatment disrupts
Rab39a-mediated trafficking, indicating that microtubules
participate in this process. Furthermore, our results indicate that
Rab39a is involved in the MVB–inclusion interaction. Notably,
Rab39a promotes the delivery of both MVBs and sphingolipids to
the growing inclusions. Our findings establish that Rab39a-
controlled transport plays a role in inclusion development and
chlamydial replication, therefore favouring the intracellular
growth of this highly adapted human pathogen.
RESULTS
Rab39a localization to chlamydial inclusions
C. trachomatis, as for many other intracellular pathogens, have
developed different strategies to survive and replicate within
infected cells. By recruiting certain Rabs and excluding others,
these bacteria avoid degradation in the phagocytic pathway and
intercept vesicles carrying host molecules required for bacterial
growth (Damiani et al., 2014; Gutierrez, 2013). Although several
researchers have explored the participation of Rabs in chlamydial
infection, this issue is far from being fully understood.
In this study,we analysed the role ofRab39a, a poorly characterized
small GTPase, in the intracellular development of C. trachomatis
serovar L2. In uninfectedHeLa cells, endogenousRab39a displayed a
punctate pattern throughout the cytosol, resembling that of small
endosomes (Fig. 1A, left panels). Interestingly, there was an evident
redistribution of endogenous Rab39a upon C. trachomatis infection,
with it being re-localized to the chlamydial inclusion periphery
(Fig. 1A, right panels). Endogenous Rab39a clearly associated with
mid-stage inclusions in almost every cell. Furthermore, images
suggest an apparent increment in the amount of Rab39a protein upon
Fig. 1. Rab39a is recruited to the inclusion of Chlamydia
trachomatis. (A) Uninfected HeLa cells (left panels) and cells
infected with C. trachomatis serovar L2 (MOI 1) for 24 h (right
panels). Endogenous Rab39a was detected using rabbit anti-
Rab39a followed by goat Cy3-labelled anti-rabbit-IgG (red)
antibodies. DNAwas stained with DAPI (blue). Asterisks show the
inclusions. Images are representative of two independent
experiments. (B) HeLa cells overexpressing EGFP or EGFP–
Rab39a-WT (green) were infected with C. trachomatis L2 (MOI 1)
for 18 h. Inclusion membrane was labelled with polyclonal rabbit
anti-IncG followed by goat Cy3-labelled anti-rabbit-IgG (red)
antibodies. Right panels show the intensity profiles scanned along
the line crossing the inclusion. The red peaks correspond to the
bacterial protein IncG and the green peaks indicate EGFP–
Rab39a. The percentage of cells in which EGFPor EGFP–Rab39a
were found flanking the inclusions during the analysis of the
intensity profiles is indicated at the bottom of the corresponding
panels. The data are representative of three independent
experiments, with 180 cells of each condition analysed (P<0.01,
Student’s t-test). (C) HFF cells overexpressing EGFP–Rab39a-WT
(green) were infected with C. trachomatis serovar L2 (MOI 1) for
18 h. Bacterial IncA was immunodetected with polyclonal rabbit
anti-IncA followed by goat Cy3-labelled anti-rabbit-IgG (red)
antibodies. The right panel shows the intensity profile scanned
along the line crossing the inclusion. (D) HeLa cells overexpressing
EGFP–Rab39a-WT (green) were infected with C. trachomatis
serovar D (MOI 1) for 18 h. The right panel shows the intensity
profile scanned along the line crossing the inclusion. The green
peaks show EGFP–Rab39a surrounding the inclusion developed
by C. trachomatis serovar D. Scale bars: 10 µm.
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infection. Hence, we analysed the expression of endogenous Rab39a
in HeLa cells infected with C. trachomatis at different hours post
infection (hpi). Our results show that eukaryotic Rab39a expression
did not significantly change upon bacterial infection (supplementary
material Fig. S1A). Detection of endogenous Rabs at chlamydial
inclusionborders is a difficult task,which has beenonlyaccomplished
for Rab14 (Capmany and Damiani, 2010). We next examined the
intracellular localization of EGFP–Rab39a in infected cells in which
inclusions were detected by immunostaining against the bacterial
protein IncG (Fig. 1B, lower panels). Similar to the endogenous
protein, EGFP–Rab39a concentrated around inclusions in almost
every infected cell (91.2%±1.2, mean±s.e.m., n=180, P<0.01, from
three independent experiments). The localization of fluorescent
proteins was analysed by generating a profile of the intensity
distribution of each constituent along a line traversing the
chlamydial inclusions. EGFP–Rab39a (Fig. 1B, green line) was
found flanking mid-stage inclusions where the bacteria (Fig. 1B, red
line) were confined.
To determine whether the association of Rab39a with
C. trachomatis inclusions occurs in other cell types, we examined
EGFP–Rab39a localization in infected HFF cells, a human foreskin
fibroblast cell line, and in CHO cells, a Chinese hamster ovary cell
line. Similar to the results obtained in HeLa cells, EGFP–Rab39a
was found surrounding chlamydial inclusions in both of these cell
types (Fig. 1C; and data not shown). Next, we examined the
intracellular distribution of this GTPase in HeLa cells infected with
C. trachomatis serovar D to assess whether Rab39a association with
inclusions depends on Chlamydia serovar. Likewise, images and
intensity profiles showed that EGFP–Rab39a was concentrated
around mid-stage inclusions (Fig. 1D). Taken together, our findings
suggest that both endogenous and overexpressed Rab39a are
recruited to chlamydial inclusions.
Characterization of Rab39a recruitment to chlamydial
inclusions
C. trachomatis gene expression varies throughout development, thus,
inclusions might display different features throughout time. To test
this possibility, we analysed the intracellular localization of EGFP–
Rab39a in HeLa cells infected with C. trachomatis for different
periods of time. Representative images and the percentage of cells
displaying a similar pattern are indicated at the bottom of each panel
in Fig. 2A. At early stages (4 hpi), multiple non-fused chlamydial
vacuoles that were trafficked to the perinucleus began to accumulate
EGFP–Rab39a. At mid-cycle (8 hpi to 12 hpi), EGFP–Rab39a was
concentrated around the clustered inclusions at the perinuclear
region of infected cells. By 18 hpi, the EGFP–Rab39a association
with the single large perinuclear inclusion was much more
prominent. Furthermore, EGFP–Rab39a remained associated with
the inclusions throughout the entire chlamydial developmental cycle.
Interestingly, at later stages of infection (32–48 hpi), several EGFP–
Rab39a-labelled small vesicles appeared to locate inside inclusions in
more than half of the cells analysed (Fig. 2A, lower right panels). To
determine whether these vesicles are within the inclusion lumen, we
stained the bacterial and eukaryotic DNAwith Hoechst 33342 (blue)
and assessed the subcellular localization of Rab39a-labelled
structures by three-dimensional (3D) fluorescence microscopy.
A series of z-optical sections were taken through the entire
thickness of the cell for a 3D-reconstruction, in which we observed
EGFP–Rab39a labelled vesicles (green) close to the bacteria (blue).
A single x-y section of the cell is shown in Fig. 2B, and x-z and y-z
projections are on the bottom and on the right side of the merged
panel, respectively. Images show some EGFP–Rab39-labelled
vesicles inside late-stage inclusions (black arrowheads), often
adjacent to bacteria (white arrowhead). In cells infected for 32 h,
we observed the presence of at least one EGFP–Rab39a-labelled
vesicle inside inclusions in the majority of the cells (72%, n=60).
Next, we assessed the association of Rab39a with inclusions
using spinning-disk microscopy in living cells to avoid fixation
artefacts. Live-cell imaging revealed a highly dynamic vesicular
trafficking between EGFP–Rab39a-positive compartments and the
inclusions at different stages of chlamydial development. For these
experiments, HeLa cells were infected for different periods of time
with C. trachomatis transformed strains overexpressing mCherry
protein (red) (Agaisse and Derré, 2013). Interestingly, small EGFP–
Rab39a-positive vesicles move forward and backward near the
chlamydial inclusions, suggesting fusion and fission events
between Rab39a-positive structures and the inclusions (Fig. 2C;
supplementary material Movie 1).
A series of experiments was performed to assess the involvement
of bacterial proteins in the recruitment of Rab39a to chlamydial
inclusions. HeLa cells overexpressing EGFP–Rab39a (green) were
incubated with living or heat-killed C. trachomatis detected with
anti-elementary-body antibodies (red). DAPI staining labelled
bacteria and the host cell nuclei (blue). Images show that EGFP–
Rab39a did not associate with dead bacteria (supplementary
material Fig. S1B). Furthermore, EGFP–Rab39a failed to localize
to chlamydial inclusions in the presence of chloramphenicol, a
bacterial translation inhibitor, but resumed upon removal of the
antibiotic (supplementary material Fig. S1C; data not shown).
These data suggest that C. trachomatis-mediated remodelling of the
inclusion is necessary for recruitment of Rab39a.
To determine the specificity of the interaction between Rab39a and
chlamydial inclusions, HeLa cells overexpressing different Rab
GTPases were infected with C. trachomatis for 24 h. Cells were
processed for immunofluorescence with anti-IncA antibodies.
Consistent with previous data (Rzomp et al., 2003; Scidmore et al.,
2003), although adjacent to the inclusions, Rab5 (see Fig. 4Bf–h) and
EGFP–Rab7a (Fig. 3A, upper panels) did not associate with the
inclusions. In contrast, this is the first report showing that the
endocytic and lysosomal Rab34 (Fig. 3A, second row), whose short
variant is Rab39, and Rab39b (Fig. 3A, lower panels), an isoform that
functions at the ER–Golgi were recruited to the chlamydial inclusions
interface. The percentage of cells in which Rabs were found to be
associated with the inclusions is indicated in each case.
Next, we investigated whether Rab39a association with the
inclusions depends on its GTP- or GDP-binding state by
overexpression of the constitutively active GTP-bound (EGFP–
Rab39a-Q72L) or the inactive GDP-bound (EGFP–Rab39a-S22N)
Rab39a mutant proteins. Images and intensity distribution profiles
show that wild-type (WT) Rab39a and Rab39a Q72L, but not
Rab39a S22N, localized at chlamydial inclusions (shown by IncA-
labelling) (Fig. 3B), indicating that Rab39a is recruited to the
chlamydial inclusions in a guanine-nucleotide-dependent manner.
Distribution intensity profiles of 50 cells for each condition were
analysed to calculate the percentage of cells depicting positive
recruitment of each GFP to the boundaries of the inclusions. In
agreement with these findings, mutants of Rab4, Rab6, Rab11 and
Rab14 only able to bind GDP do not associate with chlamydial
inclusions (Capmany and Damiani, 2010; Moorhead et al., 2007;
Rzomp et al., 2006).
Both, chlamydial inclusion migration to the perinucleus and
homotypic fusion are dependent on an intact microtubule network
(Grieshaber et al., 2003; Richards et al., 2013). Furthermore, it has
been recently demonstrated that microtubule depolymerization
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reduces inclusion growth and chlamydial replication in cells treated
with nocodazole for long periods of time (Al-Zeer et al., 2014).
Live-cell imaging showed EGFP–Rab39a-positive vesicles
moving along straight lines, likely microtubules (supplementary
material Movie 1). Therefore, we analysed the effect of
nocodazole, a microtubule-destabilizing drug, on uninfected and
C.-trachomatis-infected cells. Time-lapse video microscopy shows
that the movement of Rab39a-positive vesicles in uninfected cells
was drastically reduced after a short-term treatment with
nocodazole (10 µM, 1 h) (supplementary material Movie 2, right
panel). Consistent with this, Rab39a-positive vesicle movement
was almost suppressed in C.-trachomatis-infected cells after
nocodazole treatment (supplementary material Movie 3, right
panel). Crucially, we found that altering microtubule integrity
impaired Rab39a recruitment to the chlamydial inclusions
(Fig. 3C, white arrowheads). Depolymerization of the
microtubular network was confirmed by tubulin staining.
Collectively, live-cell imaging and confocal microscopy suggest
that C. trachomatis modify the inclusion early during the
developmental cycle to recruit Rab39a, and that Rab39a
association with inclusions is GTP-dependent and involves
dynamic microtubules.
Rab39a colocalizes with CD63 and LBPA in C. trachomatis-
infected cells
To understand the implications of Rab39a recruitment to chlamydial
inclusion development, we examined the subcellular distribution of
this GTPase in both uninfected (Fig. 4A) andC. trachomatis-infected
(Fig. 4B) HeLa cells. Intracellular distribution of EGFP–Rab39a in
uninfected cells is more extensively displayed in supplementary
Fig. 2. Rab39a associates with chlamydial
inclusions throughout the developmental cycle.
(A) HeLa cells transiently overexpressing
EGFP–Rab39a-WT (green) were infected with
C. trachomatis serovar L2 at an MOI of 25 (for 4 h to
12 h assays) and of 5 (for 18 h to 48 h assays). At
the indicated post infection times (hpi), cells were
fixed and stained with Hoechst 33342, which labels
bacterial and eukaryotic DNA (blue). Insets show a
magnification of the perinuclear region of infected
cells at early stages of chlamydial inclusion
development. Scale bars: 10 µm. Images are
representative of two independent experiments.
The percentage of cells with similar patterns is
indicated at the bottom of the panels. (B) A single
x-y section from the stack of images of a cell
infected for 32 h, and x-z and y-z projections on the
bottom and left side of the right panel, respectively.
In the projections, black arrowheads point to the
Rab39a-labelled vesicles that are inside the
inclusion next to the bacteria, which is indicated by
an open arrowhead. (C) HeLa cells transiently
overexpressing EGFP–Rab39a were infected with
C. trachomatis transformed strains harbouring
p2TK2-SW2 IncDProm-mCherry-IncDTerm
(mCherry) for 24 h. Insets show a magnification of
the inclusion area. Numbered panels showa gallery
of time-lapse images acquired every 2 s by spinning
disk microscopy (from supplementary material
Movie 1). The nucleus of the cell is indicated with
N. White arrowheads point to a Rab39a-positive
vesicles coming and detaching from the inclusion.
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material Fig. S2. Colocalization assays of EGFP–Rab39a with well-
characterized markers of the Golgi complex and endocytic organelles
were performed first in uninfected cells and then in cells infected
withC. trachomatis for 18 h. Pearson correlation coefficients (r) were
calculated and are indicated at the bottom of the panels in
Fig. 4B. Interestingly, images show that EGFP–Rab39a did not
localize to the Golgi complexes – labelled with anti-TGN46 (also
known as TGOLN2) or with anti-GM130 antibodies – in uninfected
or infected cells (Fig. 3D; Fig. 4Aa,Bb–d). Consistent with this,
Rab39a association with chlamydial inclusions was not affected by
brefeldin A (BFA) treatment (Fig. 3D, right panel). Early endosomes,
identified with anti-Rab5 antibodies, localized at the cell periphery
and displayed little overlap with EGFP–Rab39a (Fig. 4Ae,Bf–h).
Similar results were obtained by loading early endosomes with
Texas-Red-conjugated dextran (data not shown). By contrast, EGFP–
Rab39a displayed a high degree of colocalization with LysoTracker
(a marker of acidic compartments) (Fig. 4Ai,Bj–l) and lysosome-
associated membrane protein 1 (LAMP1) (Fig. 4Am,Bn–p), not only
in uninfected cells but also at the vicinity of the chlamydial
inclusions. Surprisingly, there was little colocalization between
EGFP–Rab39a and cathepsin D in either condition (Fig. 4Aq,Br–t),
indicating that Rab39a labels a subset of vesicles from the late
endocytic pathway that are devoid of cathepsin D. In agreement
with our findings, it has been reported that Rab39a regulates
Fig. 3. Characterization of Rab39a recruitment to chlamydial
inclusions. (A) HeLa cells were transiently transfected with
pEGFP-Rab7a WT (upper panels), pEGFP-Rab34 WT (upper
middle panels), pEGFP-Rab39a WT (lower middle panels) or
pEGFP-Rab39b (lower panels), and 24 h later, cells were infected
with C. trachomatis serovar L2 (MOI 1) for 24 h. Inclusion
membrane and bacteria were immunodetected with polyclonal
rabbit anti-IncA followed by goat Cy3-labelled anti-rabbit-IgG (red)
antibodies. Insets show amagnification of the selected areas. The
percentage of cells in which the corresponding Rab is found
associated with the inclusion borders, as assessed by analysis of
distribution intensity profiles (40 cells of each condition were
analysed from three independent experiments) are shown at the
bottom of the panels. (B) HeLa cells transiently transfected with
pEGFP, pEGFP-Rab39a WT, pEGFP-Rab39a S22N (GDP-
bound form) or pEGFP-Rab39a Q72L (GTP-bound form) were
infected with C. trachomatis serovar L2 (MOI 1) for 18 h and
analysed by confocal microscopy. Inclusion membrane and
bacteria were immunodetected with polyclonal rabbit anti-IncA
followed by goat Cy3-labelled anti-rabbit-IgG (red) antibodies.
DNA was stained with DAPI (blue). Lower panels show the
intensity profiles scanned along the line crossing the inclusion.
The percentage of cells in which the indicated proteins were found
flanking the inclusions in the analysis of the intensity profiles are
displayed at the bottom of the panels. Datawere obtained from two
independent experiments (50 profiles of each condition
were analysed). (C,D) HeLa cells were transfected with
pEGFP-Rab39a WT (green) and 24 h later were infected with
C. trachomatis serovar L2 (MOI 5). After the internalization period
(2 h), cells were washed to remove non-internalized bacteria and
incubated for 1 h with complete medium. Then, (C) nocodazole
(NZ, 2 µM) or (D) brefeldin A (BFA, 1 µg/ml) was added, and
finally, cells were fixed at 18 hpi. White arrowheads indicate
chlamydial inclusions. Tubulin and the Golgi marker GM130 were
detected using specific monoclonal mouse antibodies followed by
goat Cy3-labelled anti-mouse-IgG (red) antibody. DNA was
labelled with DAPI (blue). Scale bars: 10 µm.
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phagosomal acidification, but not cathepsin D recruitment, to
Mycobacterium tuberculosis-containing phagosomes (Seto et al.,
2011).
To further characterize the nature of Rab39a-positive subcellular
structures, we analysed their localization in conjunction with that of
markers for MVBs, which are late endocytic organelles enriched in
LBPA. Interestingly, there was a high degree of colocalization
between EGFP–Rab39a (green) and LBPA (red) in both, uninfected
and infected cells (Fig. 4Au,Bv–x). In addition, MVBs were also
identified by labelling the tetraspanin CD63 (red), and it was found
that this marker showed almost complete colocalization with
EGFP–Rab39a (green) in C. trachomatis-infected cells, as shown
in Fig. 5A [the Pearson correlation coefficient (r) is indicated at the
bottom of the right panel]. Furthermore, vesicles dually labelled
with Rab39a and CD63 were clearly detected within the lumen and
surrounding the inclusions (Fig. 5A, inset). A 3D image built with
the z-slices of the cell is shown in supplementary material Movie 4,
in which Rab39a and CD63 double-positive small vesicles can be
observed inside the inclusion that it is delimited by Rab39a
association to its borders.
To more accurately assess the interaction between MVBs
and chlamydial inclusions, we performed ultra-structural analysis
of infected cells. EGFP–Rab39a-overexpressing cells were first
infected with C. trachomatis for 24 h. Then, the nature of
the vesicles observed within the inclusion lumen as well as in
the vicinity of the inclusions was further analysed by
immunodetecting CD63. Electron microscopy images show
vesicular structures dually labelled with Rab39a and CD63,
confirming their identity as MVBs (Fig. 5Ba,b; supplementary
material Fig. S3a, black arrows). Several MVBs are in close contact
with the chlamydial inclusion membrane, suggesting tight
interaction and fusion events between both structures (Fig. 5Ba,b;
supplementary material Fig. S3a, black arrowheads). Furthermore,
both the proteins EGFP–Rab39a and CD63 were found to be
associated with vesicular structures that were adjacent to bacteria,
which might be delivered to the lumen of chlamydial inclusions by
fusion with Rab39a-positive MVBs (Fig. 5Ba,b, open arrowheads).
Several bacteria are indicated with asterisks. In addition, Rab39a
was found within the lumen and was associated with the inclusion
membrane (Fig. 5Bb, white arrows). In another experiment,
Fig. 4. Rab39a localizes at the late endocytic pathway.
HeLa cells transiently overexpressing EGFP–Rab39a
(green), (A) uninfected or (B) infected with C. trachomatis
serovar L2 (MOI 1) for 18 h, were stained with markers of
different subcellular structures: TGN46 (for the trans-Golgi
network, a–d), Rab5 (for early endosomes, e–h),
LysoTracker (for acidic compartments, i–l), LAMP1 (for late
endosomes and lysosomes, m–p), cathepsin D (for
hydrolytic enzymes, q–t) and LBPA (for multivesicular
bodies, u–x). Cells were incubated with LysoTracker (red) for
10 min prior to fixation or were inmunolabelled with the
appropriate primary antibodies followed by goat Cy3-labelled
anti-mouse-IgG (red) antibody, as indicated. Scale bars:
10 µm. Images are representative of three independent
experiments. Pearson’s colocalization coefficients (r)
between Rab39a and the different organelle markers are
shown at the bottom of the right panels (data are from three
independent experiments in which 50 cells of each group
were analysed).
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EGFP–Rab39a-overexpressing cells infected with C. trachomatis
[multiplicity of infection (MOI) 1, 24 h] were allowed to internalize
bovine serum albumin (BSA)–gold conjugates for 60 min.
Internalized BSA accumulated in vesicular compartments
morphologically identified as MVBs, which were also labelled
with EGFP–Rab39a. BSAwas transported to and incorporated into
chlamydial inclusions confirming interaction with the late endocytic
pathway (supplementary material Fig. S3b, white arrowheads).
Rab39a was found to be associated with the inclusion membrane as
well as within the inclusion lumen (supplementary material Fig.
S3b, white arrows). These findings imply that the arrival and
incorporation into the inclusions of molecules internalized by
endocytosis is mediated through selective sorting and delivery of a
subset of late endocytic organelles, likely MVBs, and that this
process involves a Rab39a-mediated trafficking pathway.
Rab39a is involved in the transport of MVBs and
sphingolipids to the inclusions
The participation of Rab39a in the transport of MVBs to chlamydial
inclusions was further analysed using loss-of-function approaches.
Fig. 5. Rab39a localizes at
multivesicular bodies and mediates
their transport to chlamydial
inclusions. (A) HeLa cells transiently
overexpressing EGFP–Rab39a-WT
(green) were infected with C.
trachomatis serovar L2 (MOI 1) for 24 h
and stained with mouse anti-CD63
antibodies followed by goat Cy3-
labelled anti-mouse-IgG antibodies
(red). The inset shows amagnification of
the selected area. Scale bar: 10 µm.
(B) Ultrathincryosections (a,b) of C.
trachomatis-infected cells (MOI 1, 24 h)
were double immunogold labelled for
CD63 (PA-G15) and Rab39a (PA-G10).
Several multivesicular bodies (MVBs)
labelled for CD63 and Rab39a were
closely apposed to the limiting
membrane of the chlamydial inclusion
(black arrows). Note CD63 and Rab39a
double-positive MVBs that were
probably undergoing fusion with the
chlamydial inclusion at the time of
fixation (black arrowheads). Small
vesicular structures, dually labelled with
CD63 and Rab39a, were found within
inclusion lumen in close contact with
bacteria (open arrowheads). Several
bacteria are highlighted with asterisks.
Rab39awas found to be associated with
the chlamydial inclusion membrane
(b, white arrows). Scale bars: 200 nm.
(C) HeLa cells were transfected with
control siRNA or specific Rab39a (1)
siRNA and infected with C. trachomatis
L2 (MOI of 5) at 48 h post transfection.
Then, cells were fixed at 24 hpi and
bacteria were labelled with FITC-
coupled anti-MOMP antibodies (green)
and MVBs with mouse monoclonal anti-
CD63 followed by goat Cy3-labelled
anti-mouse-IgG antibodies (red). DAPI
stained eukaryotic and bacterial DNA
(blue). Scale bars: 10 µm. Images are
representative of three independent
experiments. Note the decrease in the
amount of CD63 labelling within
inclusion lumen in Rab39a-depleted
cells (lower panels).
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HeLa cells were transfected with small interfering RNAs (siRNAs)
against luciferase (control cells) or with specifically designed
siRNA against Rab39a [Rab39a (1) siRNA]. At 48 h post-
transfection, control and Rab39a-depleted cells were infected with
C. trachomatis for 24 h. MVBs were labelled with anti-CD63
antibodies (red), bacteria with anti-MOMP antibodies (green) and
DNA with DAPI (blue). Noticeably, the localization of CD63 at
chlamydial inclusions decreased when Rab39a expression was
knocked down (Fig. 5C, lower panels). These results indicate that
Rab39a might accomplish a role in the re-routing of MVBs to the
chlamydial inclusions.
MVBs are a major source of lipids for growing inclusions.
Therefore, we investigated whether Rab39a is involved in
sphingolipid delivery from these organelles to the inclusions.
HeLa cells overexpressing EGFP (control), EGFP–Rab39a-WT,
EGFP–Rab39a-S22N or EGFP–Rab39a-Q72L were infected with
C. trachomatis for 18 h. Before fixation, cells were incubated
with BODIPY-Tr-Ceramide (red), a fluorescently labelled
precursor usually used to analyse transport of endogenously
synthesized sphingomyelin to the inclusions. Interestingly, a high
degree of colocalization between EGFP–Rab39a-WT and
sphingolipids was observed at the chlamydial inclusion
membrane and in vesicles nearby (Fig. 6A, see insets). The
right panels of Fig. 6A show distribution intensity profiles of
EGFP-tagged proteins (green line) and sphingolipids (red line)
along a line traversing the chlamydial inclusions. Cells
overexpressing EGFP–Rab39a-WT or its active GTP-bound
mutant (EGFP–Rab39a-Q72L) showed a significantly increase
in the amount of sphingolipids accumulated within the inclusions
compared to control or the cells overexpressing inactive mutant,
as assessed by measuring the intensity of red fluorescence
associated with inclusions by confocal microscopy (Fig. 6B).
These results point to a role for Rab39a in sphingolipid transport
to chlamydial inclusions.
We confirmed the participation of Rab39a in the delivery of host
sphingolipids to the inclusions by RNA interference loss-of-function
assays. HeLa cells were transfected with siRNAs against luciferase
(control cells) or with specifically designed siRNA against Rab39a
Fig. 6. Rab39a regulates the delivery of
sphingolipids to chlamydial inclusions.
(A) HeLa cells overexpressing EGFP,
EGFP–Rab39a-WT, EGFP–Rab39a-S22N
or EGFP–Rab39a-Q72L (green) were
infected with C. trachomatis serovar L2
(MOI 5) for 18 h. Before fixation, cells were
incubated 30 min with 5 µM BODIPY-Tr-
Ceramide (red) and chased for 30 min.
Insets show a magnification of a chlamydial
inclusion. Right panels show the intensity
distribution profiles scanned along a line
crossing the inclusion. (B) Bar graph
representing the fluorescence intensity of
the red labelling (sphingolipids) inside the
inclusions, as quantified by confocal
microscopy and expressed as arbitrary
units. Data were obtained from three
independent experiments (n=40,
**P<0.001, one-way ANOVA and
Bonferroni’s multiple comparison test).
(C) HeLa cells were transfected with control
siRNA or Rab39a (1) siRNA for 48 h. Then
cells were infected with C. trachomatis L2
(MOI of 5) and fixed at 24 hpi. Before
fixation, cells were incubated for 30 min with
a different lipid probe, BODIPY-FL-
Ceramide, and chased for 30 min. At high
concentrations BODIPY-FL-Ceramide
exhibits red fluorescence whereas in low
concentration this ceramide displays green
fluorescence. DNA was labelled with DAPI
(blue). Dotted lines delimit the inclusions
that are highlighted by the arrows. Scale
bars: 10 µm.
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[Rab39a (1) siRNA]. At 48 h post-transfection, cells were infected
withC. trachomatis for 24 h. Before fixation, cells were incubated for
30 min with ceramide coupled to a different fluorescent compound
(BODIPY-FL-Ceramide). In this latter case, sphingolipids exhibit red
fluorescence at high concentrations, whereas at low concentrations
they display green fluorescence. Images confirm the sphingolipid
accumulation within inclusions of control cells (denoted by the red
fluorescence inside inclusions; Fig. 6C, upper panels). By contrast,
the amount of sphingolipids within chlamydial inclusions was
significantly reduced in Rab39a-depleted cells, which only displayed
weak green fluorescence at the inclusion area (Fig. 6C, lower panels).
Taken together, these data indicate that Rab39a controls the transport
of sphingolipids to the developing chlamydial inclusions.
Rab39a promotes inclusion development and chlamydial
replication
C. trachomatis-driven recruitment of Rab39a to the inclusions, and
the participation of this Rab in sphingolipid delivery to the growing
inclusions suggest that this GTPase plays a role during infection
development. To address whether this was the case, HeLa cells were
depleted of endogenous Rab39a using specifically designed siRNA
(as indicated in the section above). Rab39a depletion (69%) was
confirmed by western blotting (Fig. 7B). At 48 h post transfection,
cells were infected withC. trachomatis for an additional 48 h. Then,
cells were lysed to collect the bacterial progeny. The harvested
infectious particles were titrated, in serial dilutions, on HeLa cells.
At 24 hpi, inclusions were labelled with anti-MOMP (an IgG that
recognizes the major outer membrane protein present in every
developmental form of C. trachomatis) and anti-elementary-body
(an IgG that only identifies elementary bodies) antibodies. Images
show that fewer inclusions were generated when the progeny
collected from Rab39a-depleted cells was assayed (Fig. 7A, lower
panels). The yield of infectious bacteria was quantified by
determining the number of inclusion-forming units (IFUs).
Silencing of Rab39a reduced the number of infectious progeny
(Fig. 7C). Similarly, silencing of distinct Rabs (Rab6, Rab11 and
Rab14) reduces but does not suppress bacterial replication and
infectivity (Capmany and Damiani, 2010; Rejman Lipinski et al.,
2009). Next, two siRNA against Rab39a; Rab39a (1) siRNA or
Rab39a (3) siRNA and a combination of both siRNAs (1 and 3)
were used to transfect cells. Rab39a depletion was assessed by
western blotting (Fig. 7D,E). In this set of experiments, at 48 h post-
transfection with siRNA, cells were infected withC. trachomatis for
24 h. Inclusions were detected with anti-MOMP antibodies and the
inclusion size area was measured by confocal microscopy. Our
results show that fewer and smaller inclusions were developed in
Rab39a-depleted cells (Fig. 7F). Thus, Rab39a-depleted cells are
less efficient in the generation of a productive infection, suggesting
a failure in chlamydial replication and/or in the generation of
infectious bacteria.
The participation of Rab39a on chlamydial replication was
further confirmed in HeLa cells overexpressing EGFP (control),
EGFP–Rab39a-WT, EGFP–Rab39a-Q72L or EGFP–Rab39a-
S22N. Cells were infected for 48 h, and then lysed, and the
yield of infectious particles was titrated on HeLa cells. Bacteria
were labelled with anti-MOMP (green) and anti-elementary-body
(red) antibodies. The progenies collected from Rab39aWT or its
active GTP-bound mutant overexpressing cells generated more
and bigger inclusions compared to control or EGFP–Rab39a-
S22N-overexpressing cells (supplementary material Fig. S4A).
Accordingly, the numbers of infectious particles recovered from
cells overexpressing Rab39a WT or its active GTP-bound mutant
increased significantly, as assessed by IFU assays (supplementary
material Fig. S4B). The size of the inclusions is shown in the
scatter plot graph (supplementary material Fig. S4C). The increase
in the yield of infectious particles correlated with the enlargement
of inclusion size. In agreement with our observations, previous
reports indicate that inclusion growth and development is
accelerated in cells infected with high amounts of bacteria
(Scidmore et al., 2003).
Taken together, our findings show that the decrease in the yield of
infectious particles recovered from Rab39a-depleted cells, as well
as, from cells overexpressing the inactive Rab39a GDP-bound
mutant, was small but significant, and it was verified in all assays.
Rab39 is a short variant of Rab34, hence this latter GTPase could
be acting to overcome the detrimental effect of depletion of Rab39a
on C. trachomatis replication and infectivity. Images show a high
degree of overlap between both Rabs (Fig. 8A). Hence, we analysed
the development of chlamydial inclusions in EGFP–Rab34-WT-
overexpressing HeLa cells, in Rab39a-depleted cells and in Rab39a-
depleted cells that overexpressed EGFP–Rab34-WT. Interestingly,
overexpression of Rab34 WT did not overcome the negative impact
on chlamydial inclusion growth caused by Rab39a silencing
(Fig. 8B). Accordingly, IFU assays showed that the decrease of
bacterial progeny caused by Rab39a depletion could not be rescued
by overexpression of the closely related Rab34 GTPase (Fig. 8C).
Taken together, our results demonstrate that Rab39a is required for
an efficient inclusion development and the replication of
C. trachomatis.
DISCUSSION
Chlamydial inclusions quickly dissociate from the endocytic
pathway and avoid fusion with lysosomes (Fields and Hackstadt,
2002). Initial studies failed to identify early endocytic tracers
(dextran, transferrin, Lucifer yellow) as well as late endosomal and
lysosomal markers (mannose-6-phosphate receptor, cathepsin D,
ATPase and lysotracker) at chlamydial inclusions (Heinzen et al.,
1996; Scidmore et al., 2003; Taraska et al., 1996). In this work, we
show that internalized BSA, which accumulates in vesicular
compartments immunodetected and morphologically identified as
MVBs by electron microscopy, reaches the lumen of chlamydial
inclusions. This indicates the interaction of inclusions with
organelles of the endocytic pathway (Fig. 5B; supplementary
material Fig. S3). Typical Rabs of the endocytic pathway, like Rab5,
Rab7 and Rab9, do not associate with chlamydial inclusions
(Scidmore et al., 2003). We confirmed that Rab7, the archetypal
marker of late endocytic vesicles, is not recruited to inclusions. By
contrast, we show that the late endocytic and lysosomal Rab34
associates with chlamydial inclusions (Fig. 3A). More importantly,
endogenous Rab39a protein was detected at the borders of
chlamydial inclusions, a task that is difficult to achieve with
available antibodies owing to low protein expression (Fig. 1A).
Given that we identify Rab39a on late endocytic organelles, this
report becomes the first to demonstrate the interaction of inclusions
with a Rab that functions in the late endocytic pathway.
Recent reports have demonstrated that MVBs and lysosomes are
important for inclusion development and chlamydial replication
(Ouellette et al., 2011; Robertson et al., 2009). Despite the high
impact of these late endocytic organelles on chlamydial infection
outcome, the molecular mechanisms underlying their interaction are
largely unknown. We found that Rab39a is associated with late
endocytic structures that are strongly labelled with CD63
(Kobayashi et al., 2000), a tetraspanin that identifies MVBs
(Fig. 5A,B). Furthermore, our findings show that Rab39a labels a
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subset of late endocytic vesicles that are acidic, and LAMP1- and
LBPA-positive, but do not contain the hydrolytic enzyme cathepsin
D (Fig. 4A,B). Proteomic analysis of model phagosomes containing
latex beads has depicted sequential acquisition and loss of Rab
proteins as the vesicles mature to terminal phagolysosomes
(Gutierrez, 2013). Interestingly, Rab39a recruitment follows the
same kinetics as that of Rab7 on latex-bead- and Staphylococcus
aureus-containing phagosomes. Mycobacterium tuberculosis arrest
phagosome maturation by avoiding the recruitment of Rab39a.
Furthermore, Rab39a regulates phagosomal acidification, but it
does not participate in the delivery of cathepsin D to the
phagosomes (Seto et al., 2011). This latter report is in agreement
with our finding that the subset of late endocytic vesicles labelled
with Rab39a is not enriched in the hydrolytic enzyme cathepsin
D. A key point of our study is the demonstration that Rab39a, a
GTPase that controls transport at the late endocytic pathway, is
recruited to chlamydial inclusions.
Rab39a is actively recruited to inclusions throughout the entire
chlamydial developmental cycle (Fig. 2A; supplementary material
Movie 1). Cells infected with dead bacteria or treated with inhibitors
of bacterial protein synthesis display individual elementary-body-
containing vacuoles, randomly dispersed throughout the cytoplasm,
which do not acquire Rab39a (supplementary material Fig. S1B,C).
These results are in line with previous reports that indicate that
currently unknown chlamydial proteins might supersede
recruitment of host Rabs to inclusions (Betts et al., 2009; Dehoux
et al., 2011; Valdivia, 2008). In addition, Rab39a association with
chlamydial inclusions was confirmed in different cell types and with
different C. trachomatis serovars (Fig. 1C,D). However, Rab39a is
recruited to inclusions in a nucleotide-dependent manner (Fig. 3B).
This is also the case for Rab4, Rab6, Rab11 and Rab14 (Capmany
and Damiani, 2010; Moorhead et al., 2007; Rzomp et al., 2006).
Live-cell imaging shows that Rab39a-positive vesicles move at a
high speed on functional microtubules resulting in a vectorial
transport to the inclusion (Fig. 2C; supplementary material
Movies 2 and 3). In agreement with recent reports (Al-Zeer et al.,
2014; Richards et al., 2013), our results confirm the participation of
microtubules in homotypic fusion and enlargement of chlamydial
inclusions (Fig. 3C). The recruitment of certain Rabs to chlamydial
inclusions might promote selective interactions with host vesicles
containing nutrients and structural components beneficial for the
bacteria (Damiani et al., 2014).
Fig. 7. Rab39a favours bacterial multiplication and inclusion development.HeLa cells were transfected with control siRNA or specific Rab39a (1) siRNA and
infected with C. trachomatis L2 (MOI of 5) at 48 h post transfection. After 2 days, the infected cells were lysed and the infectious particles (elementary bodies,
EB) were titrated, in serial dilution, on HeLa cells. (A) Images show the inclusions developed at 24 h by progenies collected from control (upper panels) and
Rab39a-depleted (lower panels) cells. C. trachomatis was detected using FITC-coupled anti-MOMP (green) antibody or anti-elementary-body antibodies
followed by goat Cy3-labelled anti-mouse-IgG (red) antibody, and were analysed by confocal microscopy. Scale bar: 10 µm. (B) Knockdown of Rab39a
expression was confirmed by western blotting. Tubulin was used as a loading control. (C) Bar graph shows the yield of infectious particles measured as inclusion-
forming units (IFU/ml). Data are representative of three independent experiments (*P<0.01, Student’s t-test). (D–F) HeLa cells were transfected with different
Rab39a siRNA sequences as described in the Materials and Methods: siRNA (1) Rab39a, siRNA (3) Rab39a or a combination of both (1–3). At 48 h post-
transfection, cells were infected with C. trachomatis L2 (MOI 5) for 24 h. Next, cells were fixed and bacteria were detected using FITC-coupled anti-MOMP
antibody. (D) Knockdown of Rab39a expression was confirmed by western blotting. Tubulin was used as a loading control. (E) Bar graph represents the relative
expression level of Rab39a after the transfection with the different siRNAs. Data are representative of three independent experiments. ***P<0.001, one-way
ANOVA and Bonferroni’s multiple comparison test. (F) The scatter plot represents the area of inclusions. Each point represents a single inclusion. The mean
values are represented with green lines. Data are representative of three independent experiments. ***P<0.001, one-way ANOVA and Bonferroni’s multiple
comparison test.
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One well-established fact is that the growth of C. trachomatis
heavily relies upon scavenging lipids by the recruitment of lipid
factory machineries from cytosol and by the capture of Golgi-
derived vesicles, lipid droplets and MVBs from host cells (Beatty,
2006; Cocchiaro et al., 2008; Derré et al., 2011; Elwell et al., 2011;
Hackstadt et al., 1996). Actually, MVBs, organelles rich in
sphingolipids, phospholipids and cholesterol, are central to
intracellular lipid segregation (Denzer et al., 2000; Huotari and
Helenius, 2011; Piper and Katzmann, 2007; Stoorvogel et al.,
2002; Woodman and Futter, 2008) and are major providers of host-
derived lipids to growing inclusions (Beatty, 2006). In addition to
their role in exogenous material sorting, MVBs might act as
intermediates in the transport of Golgi-derived vesicles (Denzer
et al., 2000; Huotari and Helenius, 2011; Piper and Katzmann,
2007; Stoorvogel et al., 2002; Woodman and Futter, 2008). MVBs
interact with chlamydial inclusions even in the absence of CD63
(Beatty, 2008). Furthermore, specific inhibitors of sphingomyelin
biosynthesis and MVB transport drastically impair chlamydial
development, with the loss of inclusion membrane integrity and
premature release of few infectious particles (Robertson et al.,
2009). Despite the strong requirement of MVBs for bacterial
growth, the Rab protein involved in the transport of these late
endocytic organelles to the inclusions had not been described
until now.
Previous reports have shown that there are lipid droplets and
peroxisomes within the inclusion lumen, suggesting the ability of
inclusions to ‘ingest’ host organelles (Bastidas et al., 2013;
Boncompain et al., 2014). Ultra-structurally, we recognized intra-
inclusion membranes and small vesicles dually labelled with
Rab39a and CD63, probably delivered by fusion with MVBs
(Fig. 5B; supplementary material Movie 4). Silencing of Rab39a
decreases the amount of CD63-labelled vesicles that reaches the
inclusion lumen (Fig. 5C) and reduces inclusion growth (Fig. 7F).
The unexpected decrease in the size of inclusions developed
by progeny collected from Rab39a-depleted cells or cells
overexpressing the inactive Rab39a S22N mutant (supplementary
material Fig. S4C) suggests that there is a delay in inclusion growth
that could be attributed to a defect in the lipid composition of
bacteria, impairing the replication processes at initial stages.
Our findings point to a spatial colocalization and functional
connection between Rab39a andMVBs, as well as between Rab39a
and endogenously synthesized sphingolipids in infected cells
(Fig. 6A,B). Using loss-of-function approaches we demonstrate
the involvement of Rab39a in MVBs and sphingolipid transport to
Fig. 8. Impairment of C. trachomatis development in Rab39a-depleted cells is not rescued by Rab34. (A) HeLa cells were co-transfected with pEGFP-
Rab34 WT (green) and pCherry-Rab39a WT (red) and infected with C. trachomatis serovar L2 (MOI 5) for 24 h. IncA was detected with specific antibodies
followed by Cy5-conjugated anti-rabbit-IgG antibody (blue). The right panel shows a distribution intensity profile scanned along the line that crosses the inclusion.
(B) HeLa cells were transfected with control siRNA or specific Rab39a (1) siRNA as indicated. At 24 h post-transfection, cells were transfectedwith pEGFP-Rab34
WT (upper and lower panels) or the vector pEGFP (middle panels), and 24 h later, cells were infected with C. trachomatis L2 (MOI 5) for 48 h. Images show the
inclusions generated by bacterial progenies collected from Rab34-overexpressing cells (upper panels), Rab39a-depleted cells (middle panels) and Rab39a-
depleted cells that overexpress Rab34 WT (lower panels). Cells were fixed at 24 hpi and IncA was detected using anti-IncA antibodies followed by Cy5-labelled
goat anti-rabbit-IgG antibody. DNA was stained with propidium iodide (PI). Note that overexpression of Rab34 did not overcome the detrimental effect on
chlamydial development caused by Rab39a depletion. (C) Cells were treated in a similar way to B, but in this case, the harvested infectious particles (elementary
bodies) were titrated, in serial dilution, on HeLa cells to quantify the inclusion-forming units (IFU/ml). Data are representative of three independent experiments.
**P<0.01, one-way ANOVA and Bonferroni’s Multiple comparison test. Scale bars: 10 µm.
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chlamydial inclusions (Fig. 6C). Furthermore, interfering with
Rab39a function impairs the yield of infectious bacteria, as shown
by IFU assays (Fig. 7C; supplementary material Fig. S4B). Similar
to what happens after silencing other Rabs, bacterial replication and
infectivity is reduced but not suppressed (Capmany and Damiani,
2010; Rejman Lipinski et al., 2009). Despite the fact that Rab39 is a
short variant of Rab34, the detrimental impact on C. trachomatis
propagation caused by Rab39a depletion, could not be overcome by
overexpression of Rab34 (Fig. 8B,C). Taken together, these results
support the notion that these bacteria simultaneously exploit distinct
trafficking pathways to ensure their growth and replication. Among
them, our findings demonstrate that C. trachomatis hijack Rab39a-
mediated trafficking to favour their intracellular development.
Our findings are shedding light on strategies developed by
C. trachomatis to acquire nutrients from host cells, including the
re-routing of MVBs to the inclusions. Further research is needed to
fully understand the molecular mechanisms involved in MVB–
inclusion interaction. Nevertheless, the identification of a Rab
GTPase that participates in trafficking from late endocytic organelles
to the chlamydial inclusion constitutes a substantial step in
unravelling the interplay between C. trachomatis and host cells.
MATERIALS AND METHODS
Cell culture and C. trachomatis propagation
Human epithelial HeLa 229 cells, HFF cells or CHO cells (ABAC, Buenos
Aires, Argentina) were cultured in infection medium at 37°C with 5% CO2
and 95% humidified air. Infection medium contains high-glucose
Dulbecco’s modified Eagle’s medium (DMEM; GIBCO-BRL, Buenos
Aires, Argentina) supplemented with 10% fetal bovine serum (FBS)
(Internegocios SA, Buenos Aires, Argentina), 0.3 mg/ml L-glutamine (ICN
Biomedicals Inc, OH) and 1.55 mg/ml glucose (Biopack, Buenos Aires,
Argentina), without antibiotics. Opti-MEM (Invitrogen, Buenos Aires,
Argentina) was used for transfection. Chlamydia trachomatis serovar L2
and serovar D were donated and typified by the Unidad de Estudios de
Chlamydias (Facultad de Farmacia y Bioquímica, Universidad de Buenos
Aires, Argentina). C. trachomatis transformed strains harbouring p2TK2-
SW2 IncDProm-mCherry-IncDTerm were generated and kindly provided
by Agaisse and Derré (Agaisse and Derré, 2013). For bacterial propagation,
HeLa cells were infected at a multiplicity of infection (MOI) of 20 and
incubated for 48 h. Then, infected cells were lysed using Hanks’ solutions
with glass beads and elementary bodies were purified by centrifugation as
previously described (Caldwell et al., 1981). The purified elementary bodies
were suspended in 0.2 M sucrose, L-glutamine and 0.2 M phosphate buffer
(SPG; pH 7.2) and titrated by determination of inclusion-forming units
(IFUs).
Plasmids, antibodies and reagents
The plasmids pEGFP-Rab7aWT, pEGFP-Rab34WT, pEGFP-Rab39aWT,
pEGFP-Rab39a Q72L and pEGFP-Rab39a S22N were constructed in our
laboratories. The primary antibodies used were: mouse monoclonal
anti-GM130, anti-TGN46 and anti-LAMP1 from BD Biosciences (MI);
anti-tubulin, anti-actin, anti-Rab5 and anti-GFP from Abcam (MI); anti-
cathepsin D from Aviva systems biology (MI); FITC-coupled anti-MOMP
antibody from Dakocytomation (Ely, UK); anti-C. trachomatis IncG, anti-
IncA and anti-elementary-body antibody generously provided by David
Hackstadt (National Institute of Allergy and Infectious Diseases, Hamilton,
MT); anti-CD63 from Zymed (Invitrogen, France); anti-LBPA given by
Laura Delgui (IHEM, Mendoza, Argentina); and rabbit polyclonal anti-
Rab39a antibody, made at our laboratory. The secondary antibodies were:
goat Cy3-labelled anti-rabbit-IgG, goat Cy3-labelled anti-mouse-IgG, goat
horseradish peroxidase (HRP)-conjugated anti-rabbit-IgG and goat
HRP-conjugated anti-mouse-IgG antibodies purchased from Jackson
ImmunoResearch Laboratories (West Grove, PA). LysoTracker Red DND-
99, Hoechst 33342, propidium iodide and DAPI were from Molecular
Probes (Life Technologies, Buenos Aires, Argentina); nocodazole and
Mowiol were from Calbiochem (San Diego, CA) and brefeldin A (BFA),
chloramphenicol and dimethyl sulfoxide (DMSO) were from Merck
(Buenos Aires, Argentina).
Cell transfection
HeLa 229 cells were grown on 12-mm-diameter glass cover slips in 24-well
plates (ETC internacional, Buenos Aires, Argentina) until 70% confluence.
Cells were washed once with serum-free DMEM (GIBCO-BRL Buenos
Aires, Argentina) and transfected with XtremeGene 9 (Roche Applied
Science, Indianapolis, IN) or Lipofectamine 2000 (Invitrogen, Buenos
Aires, Argentina) using 1 μl per 1 µg of DNA per well according to the
manufacturers’ protocol. For silencing assays, siRNA was transfected with
Ribocellin transfection reagent (BioCellinChallenge, SAS, France). All
siRNA oligonucleotides targeting Rab39a were purchased from Thermo
scientific (Thermo, Paris, France) and the sequences used were 5′-AAUC-
UUGACGAGAGACAUA-3′ (1) and 5′-CAGGAGCGGUUCAGAUC-
AA-3′ (3). In all cases a siRNA oligonucleotide targeting firefly
luciferase (siLuc) was used as a control.
Infection and detection of C. trachomatis
HeLa cells transfected with pEGFP-Rab39a were infected 18 h later by
diluting bacterial stock in infection medium. Cells were centrifuged (450 g,
15 min, room temperature) to synchronize the infection and then incubated
for the internalization step (120 min, 37°C and 5% CO2). After that, cells
were washed two times with phosphate-buffered saline (PBS) to eliminate
non-internalized bacteria, and finally, cells were incubated in the presence of
infection medium for the indicated post infection times (hpi).C. trachomatis
was detected using DNA stains (DAPI, propidium iodide or Hoechst 33342)
or antibodies such as rabbit anti-elementary-body or FITC-coupled anti-
MOMP antibody.
Immunofluorescence and confocal microscopy
For colocalization studies, HeLa cells were grown on cover slips in 24-well
plates and transfected with the chosen plasmid at least 24 h before the
experiment, and then, cells were infected with C. trachomatis according to
the assay. To detect endogenous proteins, infected cells were fixed in 3%
paraformaldehyde (PFA) in PBS for 20 min at room temperature. Aldehydes
were quenched with 50 mM NH4Cl for 5 min. Cells were washed in PBS
and permeabilized with 0.2% saponin and 1 mg/ml BSA in PBS. After that,
cells were incubated for 60 min with the appropriate primary antibody
followed by incubation with a fluorescently labelled secondary antibody.
Coverslips were mounted inMowiol containing 0.5 µg/ml Hoechst 33342 or
DAPI for DNA staining. Optical sections of 0.21 µm thickness were
acquired for 3D reconstructions. Distribution intensity profiles were
performed and analysed with FV10 software (Olympus America, Inc.,
Melville, NY). The size of the inclusion was determined as pixel area in a
middle z-plane. An Olympus FV-1000 spectral confocal unit mounted on an
IX-25 Olympus inverted microscope was used. Images were acquired and
analysed with FV10-ASW 1.7 Software, and then processed using ImageJ
and Adobe Illustrator CS3 software.
Time-lapse fluorescence microscopy
Transfected cells were grown on glass-bottomed 35-mm dishes (Iwaki;
Asahi Techno Glass, Tokyo, Japan). Time-lapse imaging was performed at
37°C on a spinning-disk confocal microscope mounted on an inverted
motorized microscope (DMIRE2; Leica, Wetzlar, Germany) equipped with
a CSUXI spinning disk head (Yokogawa, Tokyo, Japan) and temperature
and CO2 controller (Life Imaging Services, Reinach, Switzerland). Images
were captured on a QuantEM 512SC camera (Photometrics). A z-stack of
three planes was acquired every 1 s for a period of 1 min. Movies were
generated using MetaMorph software (NY).
Immunoelectron microscopy
Cell samples were fixed in a mixture of 2% PFA and 0.125% glutaraldehyde
in a 0.1 M phosphate buffer pH 7.4 and processed for ultracryomicrotomy as
described previously (Raposo et al., 1997). Ultrathin sections were prepared
with an ultracryomicrotome Ultracut FCS (Leica) and underwent single or
double immunogold labelling with protein A conjugated to gold particles
10 nm or 15 nm in diameter (Cell Microscopy Center, Department of Cell
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Biology, Utrecht University). EGFP–Rab39a was detected with the
appropriate antibodies (from Molecular Probes) and then labelled using
protein A conjugated to 10-nm gold particles (PA-G10). CD63 was detected
with primary antibodies (from Zymed) followed by anti-mouse-IgG, and
labelled using protein A conjugated to 15-nm gold particles (PA-G15) as
reported previously (Theos et al., 2005). Sections were analysed on a Tecnai
Spirit G2 electron microscope (FEI, Eindhoven, The Netherlands) and
digital acquisitions were made with a 4k CCD camera (Quemesa, Olympus,
Münster, Germany).
RNA interference
2.5×105 cells were seeded onto six-well tissue culture plates and 24 h later
were transfected with control (2 nM of luciferase control siRNA) or
Rab39a-specific (2 nM of a mix of predesigned siRNA directed against
human RAB39A) siRNA, using Ribocellin transfection reagent and Opti-
MEM accordingly to the siRNA transfection protocol suggested by the
manufacturer. At 48 h post transfection, cells were infected with
C. trachomatis. After 2 days, the amount of infectious particles was
measured by IFU assays.
Immunoblotting
Cell lysates were resolved by western blotting. Protein levels were quantified
using a bicinchoninic acid (BCA) protein assay kit (Pierce™ Thermo
Scientific). Equal amounts of proteins were separated in 12% gradient SDS-
PAGE gels. Separated proteins were transferred onto nitrocellulose
membranes and then detected using polyclonal rabbit anti-Rab39a (1:50)
followed by goat HRP-conjugated anti-rabbit-IgG antibodies (1:5000).
Protein loading was controlled with monoclonal mouse anti-tubulin
(1:1000) or anti-actin (1:1000) and goat HRP-labelled anti-mouse-IgG
antibodies (1:5000). An Amersham ECL Plus™ kit was used to detect HRP
activity (GE Healthcare Life Sciences, Buenos Aires, Argentina).
IFU assays
Transfected cells were infected with C. trachomatis L2 for 48 h, lysed with
glass beads in SPG buffer and titrated on HeLa cells. Cell lysates were
centrifuged for 10 min at 500 g to remove debris and progressive dilutions
were inoculated onto HeLa cells seeded on 24-well plates. After 24 h, cells
were fixed, permeabilized and the bacteria were stained with FITC-coupled
anti-MOMP antibody or another specific antibody. The numbers of
inclusions formed by chlamydial progeny were counted in 30 fields by
microscopical analysis and expressed as IFUs per ml.
Statistical analysis
The data represent the mean±s.e.m. of n experiments. For simple paired
analyses between two groups, a Student’s t-test was chosen. For multiple
comparisons, ANOVA with subsequent Bonferroni’s test was used. A
P value less than 0.01 was considered to be statistically significant.
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